Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of DWC20155/DWC20156 and DWC20163 in Healthy Volunteers
NCT03005223Phase 1Unknown
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jan 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of DWC20155 and DWC20156 in gastritis and Peptic ulcer disease (PUD) (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoints: Maximum Plasma Concentration and Area under the time versus plasma concentration curve. Status: unknown.
02
Drugs
DWC20155DWC20156
03
Conditions
gastritisPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT03005223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005223.